PUBLIC CONTRACT · 2012
AQ 84/2013 Medicamentos Lamivudina (3TC) 100mg Comp; Lamivudina 150mg + Zidovudina 300mg Comp; Lamivudina 150mg Comp; Zidovudina 250mg Cáps.
- Contract value
- €202,347.40
- Signed on
- 7 December 2012
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 908423PUBLISHED SUBJECT
AQ 84/2013 Medicamentos Lamivudina (3TC) 100mg Comp; Lamivudina 150mg + Zidovudina 300mg Comp; Lamivudina 150mg Comp; Zidovudina 250mg Cáps.
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Generis Farmacêutica, SA · Tax ID 508107997
- Awardee
- Teva Pharma - Produtos Farmacêuticos, Lda · Tax ID 507045491
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €202,347.40
- Procedure base price
- €205,979.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 4 December 2013
- Award date
- 7 December 2012
- Signing date
- 7 December 2012
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- AQ 84/2013 Medicamentos Lamivudina (3TC) 100mg Comp; Lamivudina 150mg + Zidovudina 300mg Comp; Lamivudina 150mg Comp; Zidovudina 250mg Cáps.
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 1111421
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.